US FDA’s Byooviz Review By The Numbers

 
• By Sue Sutter
  
Drug Review Profile: Byooviz Chronology
Byooviz was the first biosimilar to Lucentis approved in the US. • Source: Shutterstock/Alamy

More from Biosimilars

More from Biosimilars & Generics